Sector ratings Indivior PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:29 19/09/2024 BST			5-day change	1st Jan Change
732.50 ^GBX	+0.96%		+0.83%	-38.19%

09-05	Indivior PLC Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM
09-04	Indivior reports "disappointing" results for study with Aelis Farma	AN

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Composite Consensus	Composite Visibility	ESG Refinitiv	Capi. ($)
INDIVIOR PLC				B	1.26B
MERCK KGAA				A	80.24B
KYOWA KIRIN CO. LTD.				A-	12.06B
YUHAN CORPORATION				B-	7.1B
SK BIOPHARMACEUTICALS CO., LTD.				A-	6.18B
BETTA PHARMACEUTICALS CO., LTD.				C-	2.21B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.		-	-	-	1.9B
SUPERNUS PHARMACEUTICALS, INC.	-			D+	1.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-	-	-	-	1.72B
CHANGCHUN BCHT BIOTECHNOLOGY CO.				-	1.24B
CALLIDITAS THERAPEUTICS AB				C	1.09B
KISSEI PHARMACEUTICAL CO., LTD.				-	1.09B
OSCOTEC INC.	-			-	1.03B
HK INNO.N CORPORATION				-	1.03B
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-		-	C	890M
Average				B-	8.05B
Weighted average by Cap.				B-